A groundbreaking medication designed to delay the onset of Alzheimer’s has received approval for use within the EU. The drug, which is given via an intravenous drip every two weeks, …
A new Alzheimer’s “wonder drug” has been approved for use in the US but insiders claim it will “definitely” be rejected for use in the UK. In the US, the …
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s treatment for early Alzheimer’s, making it the second therapy for slowing progression of the brain-wasting disease that will be …
The U.S. Food and Drug Administration has delayed its decision on Eli Lilly’s LLY.N experimental treatment for early Alzheimer’s disease and will hold a meeting of outside experts to discuss …
Some doctors are concerned the drugs’ benefits don’t outweigh the risks (Image: Getty) Dementia experts have raised the alarm over “significant gaps in the data” around Alzheimer’s wonder drugs, amid …
Health Canada has green lit a drug previously approved for schizophrenia and depression to treat symptoms of agitation in Alzheimer’s patients. Rexulti (brexpiprazole) oral tablets manufactured by Otsuka Pharmaceutical Canada …